Follow us on:
Breaking News
June 8, 2026
Breaking News
Breaking News
ContractPharma_Conference_2026_650x90

Roche Strikes $2.3B Nurix Deal for BTK Degrader

 
Roche Strikes $2.3B Nurix Deal for BTK Degrader

Partnership centers on bexobrutideg, with Phase 3 plans in CLL and expansion into immunology and neurology.
Read More >>

Headlines

Breaking News

Incyte Agrees to Acquire Vega Therapeutics for $1.25B

The proposed acquisition would add Vega Therapeutics’ lead candidate, VGA039, a novel monoclonal antibody, to Incyte’s hematology portfolio.

SPONSOR

[WEBINAR] From Powder to Coated Tablet: Practical Considerations for Solid Dose Manufacturing

Join Contract Pharma on June 16 as experts from Techceuticals and JRS Pharma explore the manufacturing process behind coated tablets, covering key unit operations, material selection, formulation requirements, and the fundamentals of producing tablets suitable for coating.

Breaking News
Trials & Filings

Pfizer’s Hympavzi Gets FDA Approval for Expanded Indication

The new approval is similar, though not identical, to one granted in the EU last month.

Breaking News

Barentz Opens New Office in Chesterbrook, PA

Will serve as a central hub for Barentz’s Pharma activities in North America.

SPONSOR

Manufacturing in a Tariff-Driven World: Why Commercial Biologics Capacity Must Align with Market Demand

As trade policy, regulatory scrutiny, and capital discipline reshape biologics development, sponsors are rethinking where and how commercial manufacturing is secured.

Breaking News

Stevanato Group Introduces New Proprietary Pen Injector Platform

Deora is a multi-use, fixed-dose pen injector featuring a simple pull-push mechanism for dose setting and delivery.

SPONSOR

Five Decades of Partnership in Solid Oral Dose Manufacturing

How Ropack’s evolution from service provider to strategic CMO partner reflects broader shifts in manufacturing, packaging, and quality expectations.

Featured Resources

Solution Content Center SPOTLIGHT

Ropack Pharma Solutions

Ropack Pharma Solutions, celebrating 50 years, specializes in solid oral dose formats for pharmaceutical, nutraceutical, and food products. We provide comprehensive manufacturing, packaging, and clinical trial services, delivering trusted, innovative solutions that help our partners bring key products to market.

 

Solution Center SPOTLIGHT

Aphena Pharma Solutions

Aphena Pharma Solutions is service provider in the pharmaceutical, medical device and biologics industries. Through excellence and innovation, we provide clients with a full range of pharmaceutical packaging and manufacturing services to advance their products to market–complete, on time, on budget. With our continued investment in technology, advanced packaging systems and rigorous cost control, Aphena can deliver solutions that are highly cost effective as well as comprehensive. Through every step in the product launch or transfer process including laboratory support, manufacturing, packaging and distribution, we provide clients with pharmaceutical services to help ensure a successful product launch and year-over-year growth.